Navigation Links
Genomma Lab Announces 2009 Earnings Guidance
Date:12/10/2008

MEXICO CITY, Dec. 10 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), a leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products company, announced today its 2009 earnings guidance. The Company expects to reach organic growth without considering acquisitions in the range of 21% - 22% in net sales and an EBITDA(I) margin in the range of 27% - 28%. These estimates are based on the organic growth of core products (products launched during and before 2007); the full year effect in sales of those products launched during 2008; the growth of Genomma Lab's international operations; as well as the Company's launch program of product line extensions and new brands in new categories and in those in which the Company already participates.

Genomma Lab expects to maintain its strategy of brand acquisitions and, on a timely basis, will inform the market on any completed transaction, as well as the corresponding change to the Company's earnings guidance. As of the close of the third quarter 2008, the Company had a cash balance and equivalents of Ps. 1,073 million that may be used partially or totally for potential brand acquisitions.

Genomma Lab will continue its efforts to increase its share in the Mexican personal care and over-the-counter markets. The value of such markets is approximately Ps. 75 billion(II) and Ps. 19 billion(III), respectively.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June 2008, through a combined offering
'/>"/>

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genomma Lab Internacional Acquires UNIGASTROZOL
2. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
3. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
4. WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development
5. Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
6. Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage
7. Allscripts Announces Expiration of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024
8. Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt
9. Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client
10. American Lung Association Announces Support of Pickens Plan
11. MassMutual Announces LEED-EB Certification Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... May 03, 2015 HealthPostures, a ... solutions, announces its appearance at the , May 5 ... that HealthPostures will exhibit at the conference include its ... sit stand solutions is the 6100 TaskMate Executive. Features ... control, an adjustable keyboard tray, extended platform work surface ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 Vancouver fencing company, ... now provide valuable advice to prospective clients related to their ... looking to install railings around their decks and patios. While ... questions that pop up once the person rolls up their ... of installing a railing in finding a gate that matches ...
(Date:5/2/2015)... May 02, 2015 It’s a pattern ... natural disaster strikes anywhere on this planet, cyber scammers ... sympathy and compassion for their own personal gain. ... Emergency Readiness Team) issued an alert titled “Nepal ... email scams citing the earthquake in Nepal. The scam ...
(Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
(Date:5/2/2015)... 2015 ZoomCare, the Portland-based innovator of ... to offer its new healthcare insurance to individuals and ... Health Insurance System is the nation’s first health insurance ... performance. ZOOM+ Personal Health Insurance was ZoomCare’s first such ... are subject to review and regulation by the Oregon ...
Breaking Medicine News(10 mins):Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:ZoomCare Applies to be on Oregon Exchange 2
... LOS ANGELES, Dec. 11 At its 12th ... Group presented its Help Humanitarian Award to Steve,Mosko, ... his vibrant,humanitarian spirit and commitment to children with ... audience with his,performance of Conviction of the Heart. ...
... up-front preventive benefits add value to consumer-directed plan , ... Consumers are looking for ways to make the most of ... solution with Regence HSA Healthplan 2.0, which helps members manage ... Regence HSA Healthplan 2.0 pairs a high-deductible plan with a ...
... SAN ANTONIO - As cancer researchers move away from ... approaches, scientists are working to discover effective ways to ... San Antonio Breast Cancer Symposium illustrate the cutting edge ... Reductions in Breast Density Predict Potential Benefit of Tamoxifen ...
... Dec. 12 Alfacell Corporation (Nasdaq: ACEL ... financial officer and corporate secretary, will resign as an employee ... on the board of directors of Alfacell and will also ... until at least January 31, 2009. Mr. Kenyon has ...
... 12 Ogilvy Public Relations Worldwide (Ogilvy PR), ... has been awarded a five-year comprehensive communications support contract ... and Education. The work will be performed by Ogilvy ... the company,s life sciences consulting subsidiary, Feinstein Kean Healthcare ...
... Researchers not sure whether one causes the other, or ... 12 (HealthDay News) -- Adults who have panic disorder ... attacks and heart disease, but not heart-related deaths, a ... records of almost 58,000 adults diagnosed with panic disorder/attacks ...
Cached Medicine News:Health News:The Help Group's Teddy Bear Ball Salutes Sony Pictures Television President, Steve Mosko and Features Performance by Kenny Loggins 2Health News:Regence Unveils New Approach to Healthcare With Launch of HSA Healthplan 2.0 2Health News:Biomarkers: What can they tell us 2Health News:Alfacell Announces Management Update 2Health News:Alfacell Announces Management Update 3Health News:National Cancer Institute Selects Ogilvy Public Relations Worldwide for Comprehensive Multi-Year Communications Support 2Health News:Panic Disorder Linked to Higher Risk of Heart Disease 2
(Date:5/1/2015)... 1, 2015 The Institute for Healthcare Advancement ... award winners. The IHA Health Literacy Awards aim to ... on the practice of educating or empowering organizations to ... awards in three categories: innovative programs, published materials and ... Hero award. In the area of innovative ...
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... LAGUNA NIGUEL, Calif., Dec. 12, 2011  Inspiration Biopharmaceuticals, Inc. ... Company,s two lead hemophilia development programs - IB1001, a ... clinical trials for the treatment and prevention of ... an intravenous recombinant porcine factor VIII (FVIII) product, ...
... MALVERN, Pa., Dec. 11, 2011   TetraLogic Pharmaceuticals , ... drugs to treat cancer, today announced the oral presentation ... TL32711 at the 53rd ASH Annual Meeting and Exposition ... of Texas M. D. Anderson Cancer Center, demonstrated that ...
Cached Medicine Technology:Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 2Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 3Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 4Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 5TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting 2
... From Medtronic, Inc., the leader in beating ... Positioner. The new Starfish NS device is ... to broaden patient acceptance of surgical revascularization.,The ... Perform the Multi-Vessel Small Thoracotomy (MVST) ...
... system is a key component ... CAB procedures. This expertly crafted ... mounting options. The unique rail ... blade configurations as well as ...
... Guidant's fourth generation access device - XPOSE ... the heart. The XPOSE 4 Device is ... off-pump bypass surgery and to easily position ... Designed for both apical and non-apical placement ...
... fit in tight spaces easily? Introducing ... - the latest innovation in mechanical ... equipped with low-profile feet, innovative FlexLink ... greater reach, maneuverability, and access to ...
Medicine Products: